27-31 March
Denver, Orlando
Lambda Therapeutic Research and Novum Pharmaceutical Research Services will participate in AAD Annual Meeting 2026. We look forward to connecting with sponsors, biotech innovators, and industry professionals to discuss advancing dermatology clinical development.
As a Trusted CRO Partner, Lambda & Novum delivers comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide. With a focus on secure IT infrastructure and automation, Lambda ensures timely project delivery and strict adherence to global regulatory standards. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
Explore how Lambda & Novum’s full-service CRO capabilities can support your dermatology clinical development at every stage. With experience in over 105 dermatology studies across diverse indications, enrolling 42,000+ patients across 1,400+ sites, our teams bring experience in complex study designs, diverse patient populations, and global site management strategies.
We welcome the opportunity to discuss your upcoming dermatology programs and explore how our capabilities can support your development objectives. To schedule a meeting during AAD Annual Meeting 2026, please contact bd@novumprs.com
